Raiffeisen Bank International’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1K Sell
76
-4,574
-98% -$948K ﹤0.01% 685
2026
Q1
$1.02M Sell
4,650
-2,098
-31% -$523K 0.01% 382
2025
Q4
$1.64M Sell
6,748
-3,668
-35% -$938K 0.02% 275
2025
Q3
$2.82M Sell
10,416
-1,068
-9% -$292K 0.04% 212
2025
Q2
$2.96M Sell
11,484
-36
-0.3% -$8.59K 0.04% 191
2025
Q1
$2.53M Buy
11,520
+2,423
+27% +$566K 0.04% 201
2024
Q4
$2.09M Buy
+9,097
New +$2.19M 0.03% 212

Other funds holding RMD

Raiffeisen Bank International's RMD Position: Q2 2026 in Review

Raiffeisen Bank International reduced its ResMed (RMD) stake by 98% in Q2 2026, selling an estimated $948K and leaving 76 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Raiffeisen Bank International first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.96M in Q2 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Raiffeisen Bank International held 76 shares of ResMed worth $15.1K as of Q2 2026.
  • Raiffeisen Bank International sold 4,574 ResMed shares in Q2 2026, an estimated $948K.
  • ResMed made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #685 holding.
  • Raiffeisen Bank International first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's ResMed position peaked at $2.96M in Q2 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.